Fecal Transplantation and Fiber Improves Insulin in Obesity

As use of fecal microbial transplantation evolves, new research shows that a noninvasive approach ― with an oral capsule formulation ― combined with fiber supplementation significantly improved insulin sensitivity among those with severe obesity and metabolic syndrome. “We do think that this noninvasive approach will replace invasive fecal microbial transplant,” lead author Karen L. Madsen, PhD, told Medscape Medical News. […]

Continue reading »

Serious Bacterial Infection Rare in Neonatal Mastitis

(Reuters Health) – Few infants with neonatal mastitis develop bacterial infections or experience adverse events, according to a new study that suggests routine testing for bacterial infections may not be needed in many afebrile well-appearing babies. To assess the prevalence, clinical presentation and outcomes of neonatal mastitis, researchers examined data on 657 infants (median age 21 days) with mastitis who […]

Continue reading »

Prevalence of Dementia Before Age 65 Much Higher Than Expected

The global prevalence of young-onset dementia (YOD) is significantly higher than previously thought. Results of a large meta-analysis show that currently, 3.9 million individuals are living with YOD. Among these patients, symptoms of the memory-robbing disease start before age 65. Recent global YOD estimates have ranged from 42.3 to 54.0 per 100,000 population, the researchers note. However, the new study, […]

Continue reading »

Scientist explore conserved RNA elements as potential targets for anti-SARS-CoV-2 drugs

As the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the pathogen behind the coronavirus disease (COVID-19) pandemic, continues to spread, developing effective drugs to combat the viral spread is crucial. Researchers at Goethe University and their collaborators in the international COVID-19-NMR consortium have found that certain regions in the SARS-CoV-2 genome might be an appropriate target for future drugs. The […]

Continue reading »

New finding offers hope for psychosis sufferers

University of Otago scientists have opened the door to improved treatment of brain dysfunction which causes psychosis. Dr. Ryan Ward, of the Department of Psychology, says he and a team of researchers have been working on ways to model schizophrenia symptoms in animal models. “Psychosis is a debilitating aspect of schizophrenia and, while current drugs treat it well, they have […]

Continue reading »

Models suggest pandemic could increase worlds maternal and child undernutrition rate by billions

An international team of researchers has found via modeling that the COVID-19 pandemic is impacting food distribution networks to the point that billions of mothers and their children living in at-risk places face undernutrition. In their paper published in the journal Nature Food, the group describes using economic indicators and early insights into food and health system disruptions to create […]

Continue reading »

Researchers examine efficacy of CT-P59 monoclonal antibody against SARS-CoV-2 Brazil variant

The P.1 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant of concern (VOC) was first identified in Brazil and has since spread around the world, demonstrating increased transmissibility compared to the wildtype virus. This is due to several particular mutations that have also co-occurred in other highly transmissible VOCs. These mutations are generally centered on the receptor-binding domain (RBD) of […]

Continue reading »

WHO Warns Against People Mixing and Matching COVID Vaccines

GENEVA (Reuters) – The World Health Organization’s chief scientist on Monday advised against people mixing and matching COVID-19 vaccines from different manufacturers, calling it a “dangerous trend” since more data is needed about the health impact. “It’s a little bit of a dangerous trend here,” Soumya Swaminathan told an online briefing. “It will be a chaotic situation in countries if […]

Continue reading »

High-risk children over 12 to get Pfizer/BioNTech vaccine as soon as possible

We use your sign-up to provide content in ways you’ve consented to and to improve our understanding of you. This may include adverts from us and 3rd parties based on our understanding. You can unsubscribe at any time. More info Those now eligible include children aged 12-15 with severe neurodisabilities, Down’s syndrome, immunosuppression and profound or multiple learning disabilities. Children […]

Continue reading »
1 782 783 784 785 786 1,323